← FDA Drug Approvals (Drugs@FDA)
MIDOSTAURIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LOTUS PHARM CO LTD · Approved 2022-08-24
Drug application
- FDA Application #
ANDA215834- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIDOSTAURIN
- Generic name
- Midostaurin
- Active ingredients
- MIDOSTAURIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- LOTUS PHARM CO LTD
- First approval
- 2022-08-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown